GLYMIDINE


Synonyms	Glidiazine Glycodiazine Glymidine Gondafon Redul
Status
Molecule Category	UNKNOWN
ATC	A10BC01
UNII	4C5I4BQZ8F
EPA CompTox	DTXSID1023108


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
Smiles	COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1
InChI	InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C13H15N3O4S
Molecular Weight	309.35
AlogP	1.3
Hydrogen Bond Acceptor	6.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	7.0
Polar Surface Area	90.41
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	21.0

Related Entries

Cross References

Resources	Reference
ChEBI	146188
ChEMBL	CHEMBL1697838
DrugBank	DB01382
DrugCentral	1321
FDA SRS	4C5I4BQZ8F
Human Metabolome Database	HMDB0015461
PharmGKB	PA164748839
PubChem	9565
SureChEMBL	SCHEMBL34389
ZINC	ZINC000002040778

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).